A diabetes medication that lowers brain fluid pressure has cut monthly migraine days by more than half, according to a new ...

Novo Nordisk is likely to draw investor attention on Monday after the company said it is moving forward with the oral and ...

A new generation of weight-loss drugs has proven remarkably effective, hugely popular and massively lucrative in the last few ...

CHICAGO -- Adding investigational cagrilintide to a GLP-1 receptor agonist increased weight loss in adults with obesity with ...

Adults with overweight or obesity who received once-weekly ecnoglutide, a novel GLP-1 receptor agonist, had superior and ...

Phase 3 REDEFINE 1 trial found that treatment with CagriSema led to a 22.7% weight loss at 68 weeks among patients who adhered to the treatment, compared ...

In a Cleveland Clinic cohort, patients who stopped treatment for obesity had smaller weight losses to start, making these ...

Lembas was founded in 2024 by Shay Hilel (CEO), Dr. Zohar Barbash (CTO), Prof. Maayan Gal (CSO) and Dr. Daniel Bar as a ...

Once-weekly medication results in weight loss of up to 22.7% in adults without diabetes and 15.7% in those with type 2 diabetes CHICAGO, June 22, 2025 ...

Novo Nordisk on Sunday said full results from two late-stage trials of its experimental weight-loss drug CagriSema show that ...

THEY are arguably the biggest medical breakthrough of recent times. And from Monday, so-called ‘fat jabs’ will be made ...

A weight loss pill might be able to replace the notorious injections as per new studies.Researchers found that amycretin, ...